Labquality to expand clinical trial services to pharmaceuticals and biotech

Labquality corporation acquires Clinical Consulting corporation. Clinical Consulting is a Polish company that specializes in clinical trial services for pharmaceuticals, biotech, and medical device companies.

Clinical Consulting and its experienced professionals strengthen Labquality’s clinical trial offering in the medical device market and enable entry to new segments of pharmaceuticals and biotech. The acquisition supports Labquality’s strategy to build a strong full-service contract research organization (CRO). Moreover, the acquisition of Clinical Consulting continues Labquality’s internationalization process enabling access to new markets and customers.

The acquisition of Clinical Consulting enables Labquality to grow its CRO business in new market areas and customer segments.

“Clinical Consulting fits perfectly into our Labquality family and it complements our medical devices CRO and consulting businesses. Clinical Consulting enables us to enter both new markets and a new business segment of providing clinical trial services in pharmaceuticals and biotech. Additionally, our position to offer clinical trial services becomes more competitive with Clinical Consulting’s cost-effective service model,” says CEO Juha-Pekka Nuutinen from Labquality. 

“The ever-increasing requirements for data management, ICT systems, and GDPR set challenges for efficient and economical conduct of clinical trial services. As the competitive landscape changes, CRO companies need to build a larger base for their operations. Joining forces with Labquality enables us to operate more competitively in the future, and together we can meet the changes in the regulatory landscape and offer first-class CRO services to our customers,” concludes Tadeusz Baron, founder, and Managing Director of Clinical Consulting.

The acquisition strengthens Labquality’s position as a leading quality and regulatory consultancy and CRO service provider in the healthcare and health technology industries.

The acquisition does not have any impact on the current customer relationships, partnerships, or personnel of Clinical Consulting or Labquality.

For queries, please contact:

Juha-Pekka Nuutinen
CEO, Labquality
+358 40 828 3210 / jp.nuutinen@labquality.com

Tadeusz Baron
Managing Director
+48 513 344 446 / tadeusz.baron@clinicalconsulting.pl